PubMed Health⌕ Search

PubMed · 7128034

The interstitial lung diseases: a pathologist's view.

Abstract

The accurate diagnosis of the interstitial lung diseases requires that the pathologic features, whether they be derived from routine light microscopy, bronchoalveolar lavage material, ultrastructural or immunologic studies, be interpreted in the light of the clinical, roentgenographic, and physiologic presentations. The clinician must ensure that representative tissue is sampled and that the pertinent clinical data are supplied to the pathologist. Furthermore, the clinician should gain some appreciation of the pathologic changes commonly encountered. Such knowledge facilitates clinicopathologic correlations. The pathologist must ensure that the sampled tissue is handled in the most appropriate and efficient manner in order to realize the greatest diagnostic yield. In addition, the pathologist must convey to the clinician his confidence in the diagnosis as to whether the observed pathologic changes are diagnostically specific or nonspecific, in light of the clinical data. The diagnosis of interstitial disease in the immunocompromised patient entails even more intensive efforts, which must be accomplished in a very limited period of time. Only the close cooperation between clinician and pathologist can ensure diagnostic success.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

A Flint. 1982. The interstitial lung diseases: a pathologist's view.. https://pubmed.ncbi.nlm.nih.gov/7128034/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

BACKGROUND: In fair-skinned Caucasian populations both the incidence and mortality rates of cutaneous melanoma have been increasing over the past decades. With adjuvant therapies still being under investigation, early detection is the only way to improve melanoma patient survival. The influence of incisional biopsies on melanoma patient survival has been discussed for many years. This study investigates both the influence of diagnostic biopsy type and the presence of residual tumor cells in the re-excision specimen on disease free and overall survival. METHODS: After (partial) removal of a pigmented skin lesion 471 patients were diagnosed with stage I/II melanoma and underwent re-excision and a sentinel node biopsy. All patients were followed prospectively, mean follow up >5 years. Patients were divided according to their diagnostic biopsy type (wide excision biopsy, narrow excision biopsy, excision biopsy with positive margins and incisional biopsy) and the presence of residual tumor cells in their re-excision specimen. Survival analysis was done using Cox's proportional hazard model adjusted for eight important confounders of melanoma patient survival. RESULTS: The diagnostic biopsy was wide in 279 patients, narrow in 109 patients, 52 patients underwent an excision biopsy with positive margins and 31 patients an incisional biopsy. In 41 patients residual tumor cells were present in the re-excision specimen. Both the diagnostic biopsy type and the presence of tumor cells in the re-excision specimen did not influence disease free and overall survival of melanoma patients. CONCLUSIONS: Non-radical diagnostic biopsies do not negatively influence melanoma patient survival.

Biopsy↗